Progenitor Cell Therapy LLC-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Progenitor Cell Therapy LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014015
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Progenitor Cell Therapy LLC (PCT), a subsidiary of Caladrius Biosciences Inc is an external development and manufacturing company that offers cell therapy products. The company offers services that include cell and tissue processing; storage, distribution and delivery; consulting and regulatory support, and contract manufacturing; product and process development, and others. It also performs validation, internal and external auditing, consulting, training, and other services. PCT’s strategic commercial manufacturing plan is a plan that includes content of the strategic manufacturing assessment and quality risk analysis. The company serves academic, biotech, pharmaceutical and professional disciplines. PCT is headquartered in Allendale, New Jersey, the US.

Progenitor Cell Therapy LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Progenitor Cell Therapy LLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Progenitor Cell Therapy LLC, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Progenitor Cell Therapy LLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Progenitor Cell Therapy LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Progenitor Cell Therapy LLC, Medical Devices Deals, 2011 to YTD 2017 9
Progenitor Cell Therapy LLC, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Progenitor Cell Therapy LLC, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Kiadis Pharma Enters into Agreement with PCT 11
Licensing Agreements 12
Hitachi Chemical Enters into Licensing Agreement with Progenitor Cell Therapy 12
Acquisition 13
Hitachi Chemical Acquires Remaining 80.1% Interest in Progenitor Cell Therapy from Caladrius Biosciences 13
Caladrius Biosciences Sells 20% Stake in Progenitor Cell Therapy to Hitachi Chemical for USD19.4 Million 15
NeoStem Completes Acquisition Of Progenitor Cell Therapy 16
Progenitor Cell Therapy LLC – Key Competitors 18
Progenitor Cell Therapy LLC – Key Employees 19
Progenitor Cell Therapy LLC – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 21
Strategy And Business Planning 21
Oct 10, 2017: PCT GMP Manufacturing Infrastructure and Cleanroom Capacity Expands to Support Clients through Commercial Stage 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Progenitor Cell Therapy LLC, Pharmaceuticals & Healthcare, Key Facts 2
Progenitor Cell Therapy LLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Progenitor Cell Therapy LLC, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Progenitor Cell Therapy LLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Progenitor Cell Therapy LLC, Deals By Therapy Area, 2011 to YTD 2017 8
Progenitor Cell Therapy LLC, Medical Devices Deals, 2011 to YTD 2017 9
Progenitor Cell Therapy LLC, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Kiadis Pharma Enters into Agreement with PCT 11
Hitachi Chemical Enters into Licensing Agreement with Progenitor Cell Therapy 12
Hitachi Chemical Acquires Remaining 80.1% Interest in Progenitor Cell Therapy from Caladrius Biosciences 13
Caladrius Biosciences Sells 20% Stake in Progenitor Cell Therapy to Hitachi Chemical for USD19.4 Million 15
NeoStem Completes Acquisition Of Progenitor Cell Therapy 16
Progenitor Cell Therapy LLC, Key Competitors 18
Progenitor Cell Therapy LLC, Key Employees 19
Progenitor Cell Therapy LLC, Other Locations 20

★海外企業調査レポート[Progenitor Cell Therapy LLC-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sunstar Holding AG:戦略・SWOT・企業財務分析
    Sunstar Holding AG - Strategy, SWOT and Corporate Finance Report Summary Sunstar Holding AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Academic Medical Center-製薬・医療分野:企業M&A・提携分析
    Summary Academic Medical Center (AMC), a subsidiary of University of Amsterdam is a medical center that offers research and educational services. The center offers services such as treatment of patients, medical research and medical education. It provides medical treatments and services for various …
  • Cloud Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Cloud Pharmaceuticals Inc (Cloud Pharmaceuticals), formerly TeraDiscoveries Inc is a drug development company that designs and develops novel drugs and therapies for cancer, inflammation, CNS disorders, and rare diseases. The company offers molecular designs of ligands through its proprietar …
  • Orly International, Inc.:企業の戦略・SWOT・財務情報
    Orly International, Inc. - Strategy, SWOT and Corporate Finance Report Summary Orly International, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Qenos Pty Ltd:企業の戦略的SWOT分析
    Qenos Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • U.S. Energy Corp (USEG):企業の財務・戦略的SWOT分析
    Summary U.S. Energy Corp (US Energy) is an oil and gas company that offers exploration, development and production of oil and natural gas properties. The company provides maintenance of mineral properties. It operates its oil and gas prospects located in the Williston Basin of North Dakota, the Eagl …
  • Zimplats Holdings Ltd:企業の戦略・SWOT・財務分析
    Zimplats Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Zimplats Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Konami Holdings Corp (9766):企業の財務・戦略的SWOT分析
    Konami Holdings Corp (9766) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Great Wolf Resorts Inc:戦略・SWOT・企業財務分析
    Great Wolf Resorts Inc - Strategy, SWOT and Corporate Finance Report Summary Great Wolf Resorts Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • CAT Telecom Public Co Ltd:企業の戦略的SWOT分析
    CAT Telecom Public Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Magnis Energy Technologies Ltd (MNS):企業の財務・戦略的SWOT分析
    Magnis Energy Technologies Ltd (MNS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • L’Oreal SA:企業の戦略・SWOT・財務情報
    L'Oreal SA - Strategy, SWOT and Corporate Finance Report Summary L'Oreal SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Alberta Investment Management Corporation:企業の戦略・SWOT・財務情報
    Alberta Investment Management Corporation - Strategy, SWOT and Corporate Finance Report Summary Alberta Investment Management Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Range Resources Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q3, 2017
    Range Resources Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2017 Summary Range Resources Corp (Range) is independent oil, natural gas and natural gas liquids (NGL) company that explores, develops, and acquires natural gas and oil properties in the US. It has oil and …
  • Neurocrine Biosciences Inc (NBIX)-製薬・医療分野:企業M&A・提携分析
    Summary Neurocrine Biosciences Inc (Neurocrine) discovers, develops and commercializes pharmaceutical products for the treatment of neurologic, psychiatric and endocrine related diseases and disorders. Its lead product, Ingrezza (valbenazine) capsule is a US FDA approved selective vesicular monoamin …
  • Ferrellgas Partners, L.P.:企業の戦略・SWOT・財務分析
    Ferrellgas Partners, L.P. - Strategy, SWOT and Corporate Finance Report Summary Ferrellgas Partners, L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Enable Midstream Partners LP (ENBL):石油・ガス:M&Aディール及び事業提携情報
    Summary Enable Midstream Partners, LP (Enable), a subsidiary of CenterPoint Energy Inc, owns, operates, and develops natural gas and crude oil infrastructure assets. It is a limited partnership among CenterPoint Energy, OGE Energy and ArcLight Capital Partners, LLC. The company offers crude oil and …
  • Burke-Divide Electric Cooperative Inc:企業の戦略的SWOT分析
    Burke-Divide Electric Cooperative Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and maj …
  • Cascades Inc.:企業の戦略・SWOT・財務情報
    Cascades Inc. - Strategy, SWOT and Corporate Finance Report Summary Cascades Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Fidelity National Information Services Inc:企業の戦略・SWOT・財務情報
    Fidelity National Information Services Inc - Strategy, SWOT and Corporate Finance Report Summary Fidelity National Information Services Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆